{"id":186572,"date":"2026-08-05T15:35:43","date_gmt":"2026-08-05T10:05:43","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=186572"},"modified":"2026-08-05T15:35:43","modified_gmt":"2026-08-05T10:05:43","slug":"neuland-laboratories-ltd-share-price-52-week-high-2026-08-05","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/neuland-laboratories-ltd-share-price-52-week-high-2026-08-05\/","title":{"rendered":"Neuland Laboratories Ltd. (NEULANDLAB) Share Price Hits 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;;margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories Ltd.<\/a> Share Price has surged to a fresh 52-week high of Rs 20,100, marking a significant 4.21% increase from the previous close of Rs 19,288.35. This rise has brought the company&#8217;s market capitalisation to Rs 25,160.18 crore. The stock opened at Rs 19,252.75 and reached its peak at Rs 20,100, reflecting strong investor interest. The turnover for the day was Rs 5.72 crore with a volume of 2,844 shares traded. This milestone highlights the stock&#8217;s robust performance in the healthcare sector.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Neuland Laboratories Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 20,100<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 19,288.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 811.65 (+4.21%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 19,252.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 20,100<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 19,252.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2,844<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5.72 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 25,160.18 crore<\/td>\n<\/tr>\n<\/table>\n<p style=\"margin-top:0!important;\">Neuland Laboratories Ltd. (NEULANDLAB) traded at Rs 20,100. versus the previous close of Rs 19,288.35, a rise of 4.21%. The stock opened at Rs 19,252.75, reached Rs 20,100, touched Rs 19,252.75. Reported volume was 2,844.<\/p>\n<p>Today, Neuland Laboratories Ltd. Share Price opened at Rs 19,252.75 and quickly climbed to a new 52-week high of Rs 20,100. The stock&#8217;s previous close was Rs 19,288.35, and it experienced a day change of Rs 811.65, equivalent to a 4.21% increase. The day&#8217;s low matched the opening price, indicating a strong upward momentum throughout the trading session. The turnover reached Rs 5.72 crore, with a volume of 2,844 shares, suggesting active participation from investors. This price action underscores the stock&#8217;s appeal in the market, setting the stage for further analysis of its fundamentals and sector context.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_Ltd_NEULANDLAB_Fundamental_Analysis\"><\/span><strong>Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 25,160.18 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.44x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<\/table>\n<p>Neuland Laboratories Ltd. was valued at a P\/E ratio of 30.21x, a P\/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.21x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.71x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">71.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 3,385.56x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.44x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.75%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 25,160.18 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 136.63 crore<\/td>\n<\/tr>\n<\/table>\n<p>Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare.<\/p>\n<p>Neuland Laboratories Ltd. (NEULANDLAB) has a P\/E ratio of 30.21x, which is above the benchmark median of 21.71x, a difference of +39.15%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Neuland Laboratories Ltd. (NEULANDLAB) has a ROE of -2.89%, which is below the benchmark median of 10.75%, a difference of -126.88%. Neuland Laboratories Ltd. (NEULANDLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,945.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">30.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,652.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.86<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,608.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">63.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,457.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,451.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">164.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<\/table>\n<p>Neuland Laboratories Ltd. (NEULANDLAB) has a P\/E ratio of 30.21x compared with the displayed peer median of 39.86x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 25,160.18 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Neuland_Laboratories_Ltd\"><\/span><strong>Why Investors Are Watching Neuland Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Neuland Laboratories Ltd. Share Price reached a fresh 52-week high of Rs 20,100.<\/li>\n<li>Strong price action with a 4.21% increase today.<\/li>\n<li>Potential undervaluation indicated by a low P\/B ratio of 0.44.<\/li>\n<li>Challenges in profitability with negative ROE and ROCE.<\/li>\n<li>Significant market cap in the healthcare sector.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Neuland_Laboratories_Ltd\"><\/span><strong>About Neuland Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neuland Laboratories Ltd. is a prominent player in the healthcare sector, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs). The company serves a global clientele, providing high-quality APIs for various therapeutic segments. With a commitment to innovation and excellence, Neuland Laboratories Ltd. continues to expand its product portfolio and enhance its market presence. The company&#8217;s strategic initiatives aim to strengthen its position in the competitive pharmaceutical industry.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Neuland_Laboratories_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Neuland Laboratories Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories Ltd. (NEULANDLAB) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors can track Neuland Laboratories Ltd. Share Price, along with technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights on Univest. Stay informed with real-time data and comprehensive analysis to make well-informed investment decisions.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Neuland_Laboratories_Ltd\"><\/span><strong>What is the current share price of Neuland Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current share price of Neuland Laboratories Ltd. is Rs 20,100, marking a fresh 52-week high with a 4.21% increase from the previous close. The stock moved 4.21% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Neuland_Laboratories_Ltd\"><\/span><strong>What is the market capitalisation of Neuland Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories Ltd. has a market capitalisation of Rs 25,160.18 crore, positioning it as a significant entity in the healthcare sector. The company operates in the Healthcare sector. Its P\/E ratio is 30.21x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Neuland_Laboratories_Ltd\"><\/span><strong>What is the P\/E ratio of Neuland Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories Ltd. has a P\/E ratio of 30.21, which is above the sector median of 21.71, indicating a relatively higher valuation. The company trades at a P\/E ratio of 30.21x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Neuland_Laboratories_Ltds_PB_ratio_compare_to_the_sector\"><\/span><strong>How does Neuland Laboratories Ltd.&#39;s P\/B ratio compare to the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories Ltd.&#39;s P\/B ratio of 0.44 is significantly below the sector median of 1.9, suggesting potential undervaluation. The company trades at a P\/E ratio of 30.21x. Its P\/B ratio is 0.44x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_ROE_and_ROCE_of_Neuland_Laboratories_Ltd\"><\/span><strong>What are the ROE and ROCE of Neuland Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories Ltd. has a negative ROE of -2.89% and ROCE of -0.26%, indicating challenges in profitability and capital efficiency. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.75%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Neuland_Laboratories_Ltd_compare_to_its_peers\"><\/span><strong>How does Neuland Laboratories Ltd. compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories Ltd. has a higher market cap than peers like Dishman Carbogen Amcis Ltd. but faces challenges with negative ROE and ROCE. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_significance_of_Neuland_Laboratories_Ltds_52-week_high\"><\/span><strong>What is the significance of Neuland Laboratories Ltd.&#39;s 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52-week high of Rs 20,100 signifies strong investor interest and positive market sentiment towards Neuland Laboratories Ltd. The stock moved 4.21% during the session. The intraday range extended from Rs 19,252.75 to Rs 20,100.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neuland Laboratories Ltd. Share Price hits a new 52-week high at Rs 20,100. marking a 4.21% rise today. Market cap stands at Rs 25,160.18 crore.<\/p>\n","protected":false},"author":29,"featured_media":186571,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-186572","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["186571"],"rank_math_title":["Neuland Laboratories Ltd. Share Price Hits 52-Week High"],"rank_math_description":["Neuland Laboratories Ltd. Share Price hits a fresh 52-week high at Rs 20,100. Explore price action, fundamentals, and sector analysis for insights."],"rank_math_focus_keyword":["Neuland Laboratories Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Neuland_Laboratories_Ltd_NEULANDLAB_Share_Price_Hits_52_Week_High_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/186572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=186572"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/186572\/revisions"}],"predecessor-version":[{"id":186573,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/186572\/revisions\/186573"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/186571"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=186572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=186572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=186572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}